Wu J - Search Results

1

Long noncoding RNA SNHG4 promotes the malignant progression of hepatocellular carcinoma through the miR-211-5p/CREB5 axis.

Qiu J, Wang P, Chen Z, Zhou Y, Zhang G, Wang Z, Wu J, Zhu Q, Jiang C. Qiu J, et al. Among authors: wu j. Cancer Med. 2023 Apr;12(7):8388-8402. doi: 10.1002/cam4.5559. Epub 2022 Dec 23. Cancer Med. 2023. PMID: 36565037 Free PMC article.

2

ABCG2: a potential marker of stem cells and novel target in stem cell and cancer therapy.

Ding XW, Wu JH, Jiang CP. Ding XW, et al. Life Sci. 2010 Apr 24;86(17-18):631-7. doi: 10.1016/j.lfs.2010.02.012. Epub 2010 Feb 14. Life Sci. 2010. PMID: 20159023 Review.

3

Pro-apoptotic effects of tectorigenin on human hepatocellular carcinoma HepG2 cells.

Jiang CP, Ding H, Shi DH, Wang YR, Li EG, Wu JH. Jiang CP, et al. World J Gastroenterol. 2012 Apr 21;18(15):1753-64. doi: 10.3748/wjg.v18.i15.1753. World J Gastroenterol. 2012. PMID: 22553399 Free PMC article.

4

Lack of association of two common polymorphisms rs2910164 and rs11614913 with susceptibility to hepatocellular carcinoma: a meta-analysis.

Wang Z, Cao Y, Jiang C, Yang G, Wu J, Ding Y. Wang Z, et al. Among authors: wu j. PLoS One. 2012;7(6):e40039. doi: 10.1371/journal.pone.0040039. Epub 2012 Jun 29. PLoS One. 2012. PMID: 22768213 Free PMC article.

5

The therapeutic effects of tectorigenin on chemically induced liver fibrosis in rats and an associated metabonomic investigation.

Gao XX, Shi DH, Chen YX, Cui JT, Wang YR, Jiang CP, Wu JH. Gao XX, et al. Arch Pharm Res. 2012 Aug;35(8):1479-93. doi: 10.1007/s12272-012-0819-y. Epub 2012 Sep 1. Arch Pharm Res. 2012. PMID: 22941492

6

A novel 7-O-modified genistein derivative with acetylcholinesterase inhibitory effect, estrogenic activity and neuroprotective effect.

Shi DH, Yan ZQ, Zhang LN, Wang YR, Jiang CP, Wu JH. Shi DH, et al. Arch Pharm Res. 2012 Sep;35(9):1645-54. doi: 10.1007/s12272-012-0916-y. Epub 2012 Oct 9. Arch Pharm Res. 2012. PMID: 23054722

7

Dysregulation of signaling pathways and putative biomarkers in liver cancer stem cells (Review).

Song K, Wu J, Jiang C. Song K, et al. Among authors: wu j. Oncol Rep. 2013 Jan;29(1):3-12. doi: 10.3892/or.2012.2082. Epub 2012 Oct 17. Oncol Rep. 2013. PMID: 23076400 Review.

8

Associations of miR-499 and miR-34b/c Polymorphisms with Susceptibility to Hepatocellular Carcinoma: An Evidence-Based Evaluation.

Wang Z, Wu J, Zhang G, Cao Y, Jiang C, Ding Y. Wang Z, et al. Among authors: wu j. Gastroenterol Res Pract. 2013;2013:719202. doi: 10.1155/2013/719202. Epub 2013 Sep 26. Gastroenterol Res Pract. 2013. PMID: 24194751 Free PMC article. Review.

9

Expression of Potential Cancer Stem Cell Marker ABCG2 is Associated with Malignant Behaviors of Hepatocellular Carcinoma.

Zhang G, Wang Z, Luo W, Jiao H, Wu J, Jiang C. Zhang G, et al. Among authors: wu j. Gastroenterol Res Pract. 2013;2013:782581. doi: 10.1155/2013/782581. Epub 2013 Sep 30. Gastroenterol Res Pract. 2013. PMID: 24194752 Free PMC article.

10

Diverse roles of miR-29 in cancer (review).

Jiang H, Zhang G, Wu JH, Jiang CP. Jiang H, et al. Oncol Rep. 2014 Apr;31(4):1509-16. doi: 10.3892/or.2014.3036. Epub 2014 Feb 20. Oncol Rep. 2014. PMID: 24573597 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

77,171 results

Search Page

Filters